Exploring GLP-1 Receptor Agonists: Beyond Cardiometabolic Effects
In recent years, the therapeutic landscape of metabolic and cardiovascular diseases has been revolutionized by glucagon-like peptide-1 receptor agonists (GLP-1 ...
In recent years, the therapeutic landscape of metabolic and cardiovascular diseases has been revolutionized by glucagon-like peptide-1 receptor agonists (GLP-1 ...
In a groundbreaking synthesis of clinical data, a recent umbrella review spearheaded by Kong, Zhao, Zhang, and colleagues critically assesses ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine